Nucleotide excision repair proteins ERCC1 and XPC and tumor-infiltrating lymphocytes are biomarkers of neoadjuvant platinum resistance in high-grade serous ovarian cancer.

被引：0
|
作者：
Scurry, James [1 ]
van Zyl, Belinda [2 ]
Gulliver, Damien [2 ]
Otton, Geoffrey [3 ]
Bowden, Nikola [2 ]
机构：
[1] Pathol NORTH, Newcastle, NSW, Australia
[2] Univ Newcastle, Newcastle, NSW, Australia
[3] Hunter New England Hlth Serv, Newcastle, NSW, Australia
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A43
引用
收藏
页码：61 / 62
页数：2
相关论文
共 48 条
  • [21] Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
    Kyung Un Choi
    Ahrong Kim
    Jee Yeon Kim
    Ki Hyung Kim
    Chungsu Hwang
    So Jung Lee
    Won Young Park
    Sejin Jung
    Hye Jeong Choi
    Kyungbin Kim
    Journal of Ovarian Research, 13
  • [22] Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
    Choi, Kyung Un
    Kim, Ahrong
    Kim, Jee Yeon
    Kim, Ki Hyung
    Hwang, Chungsu
    Lee, So Jung
    Park, Won Young
    Jung, Sejin
    Choi, Hye Jeong
    Kim, Kyungbin
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [23] IDENTIFYING THE PLATINUM-SENSITIVE HIGH GRADE SEROUS OVARIAN CANCER; THE SYNERGY BETWEEN HOMOLOGOUS RECOMBINATION AND NUCLEOTIDE EXCISION REPAIR
    Faraahi, Z. F.
    Tyagi, S.
    Gavrielides, N.
    Price, M.
    McCormick, A.
    Woodhouse, L.
    Crosbie, E.
    Edmondson, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1481 - 1481
  • [24] Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis
    Wang, Ye-Min
    Cai, Wei
    Xue, Qing-Ming
    Zhang, Jin-Yao
    Zhou, Lv
    Xiong, Su-Yi
    Deng, Huan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Farrag, Mayada Saad
    Abdelwahab, Khaled
    Farrag, Nesrine Saad
    Elrefaie, Waleed Elsayed
    Emarah, Ziad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2021, 33 (01)
  • [26] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Mayada Saad Farrag
    Khaled Abdelwahab
    Nesrine Saad Farrag
    Waleed Elsayed Elrefaie
    Ziad Emarah
    Journal of the Egyptian National Cancer Institute, 33
  • [27] Immune characteristics and anti-PD-1induced reinvigoration capacity of tumor-infiltrating lymphocytes in ovarian clear cell carcinoma relative to high-grade serous ovarian carcinoma
    Park, Junsik
    Lee, Yong Jae
    Kim, Jung Chul
    Lee, Jung-Yun
    CANCER RESEARCH, 2023, 83 (07)
  • [28] Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    Cocchi, Sara
    Lopacinska-Jorgensen, Joanna
    Hogdall, Estrid, V
    ANTICANCER RESEARCH, 2024, 44 (11) : 4691 - 4707
  • [29] Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC).
    Michie, C. O.
    Song, L.
    Faratian, D.
    Orr, J.
    Rye, T.
    Clark, J.
    Bartlett, J. M.
    Harrison, D. J.
    Melton, D.
    Williams, A.
    Gourley, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer.
    Isoviita, Veli-Matti
    Salminen, Liina
    Azar, Jimmy
    Hynninen, Johanna
    Lehtonen, Rainer
    Roring, Pia
    Grenman, Seija
    Farkkila, Anniina
    Hautaniemi, Sampsa
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 69 - 69
12345